org placeholder image

Nicholas Bulkowski

Returns Analyst at Ajanta Pharma USA

  • LinkedIn

Email Email: n****@ajantapharma.com

phone noPhone Number: (***)-***-****

Ever since elementary school, where my class was assigned the cliché, “What do you want to do when you grow up?” assignment, I knew my path in life. Most of my classmates wanted to be eit...

Read More

map
AJANTA PHARMA USA

AJANTA PHARMA USA

  • description Description
    Ajanta Pharma USA Inc., based in Bridgewater, New Jersey, is a wholly owned subsidiary of Ajanta Pharma Ltd. Ajanta Pharma is committed to delivering quality generic drugs to patients, throug...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 25 Million to 50 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Ajanta Pharma USA Org Chart and Mapping

Employees

Frequently Asked Questions Regarding Nicholas Bulkowski

Answer: Nicholas Bulkowski works for Ajanta Pharma USA as Returns Analyst

Answer: Nicholas Bulkowski’s role in Ajanta Pharma USA is Returns Analyst

Answer: Nicholas Bulkowski's email address is n***@gmail.com

Answer: Nicholas Bulkowski's business email address is n****@ajantapharma.com

Answer: Nicholas Bulkowski’s direct phone number is (***)-***-****

Answer: Nicholas Bulkowski works in the industry of: Pharmaceuticals

Answer: Nicholas Bulkowski is the current Returns Analyst at Ajanta Pharma USA.... Read More

Answer: Nicholas Bulkowski works Ajanta Pharma USA located at 440 Hwy 22 East, Bridgewater, New Jersey, 08807, United States

Answer: Ajanta Pharma USA's Returns Analyst is Nicholas Bulkowski

Answer: Nicholas Bulkowski contact details:

  • Phone number  :  (***)-***-****
  • Email  :  n****@ajantapharma.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access